CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,208 | +180.2% | 10,086 | +149.0% | 0.00% | – |
| Q2 2023 | $17,204 | -15.3% | 4,050 | +5.9% | 0.00% | – |
| Q1 2023 | $20,300 | -18.8% | 3,825 | -2.8% | 0.00% | – |
| Q4 2022 | $25,000 | -40.5% | 3,936 | -1.4% | 0.00% | – |
| Q3 2022 | $42,000 | +500.0% | 3,990 | +191.0% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 1,371 | +72.9% | 0.00% | – |
| Q1 2022 | $7,000 | -50.0% | 793 | -11.5% | 0.00% | – |
| Q4 2021 | $14,000 | -33.3% | 896 | +2.2% | 0.00% | – |
| Q3 2021 | $21,000 | – | 877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $10,174,000 | 6.39% |
| 72 Investment Holdings, LLC | 474,067 | $7,154,000 | 6.35% |
| Velan Capital Investment Management LP | 210,695 | $3,179,000 | 2.47% |
| PFM Health Sciences, LP | 4,092,309 | $59,418,000 | 2.02% |
| Monashee Investment Management LLC | 504,377 | $7,611,000 | 1.88% |
| CloudAlpha Capital Management Limited/Hong Kong | 415,000 | $6,262,000 | 1.49% |
| Avidity Partners Management LP | 2,674,067 | $40,352,000 | 0.86% |
| Rokos Capital Management LLP | 570,359 | $8,604,000 | 0.52% |
| Green Alpha Advisors, LLC | 35,592 | $537,000 | 0.36% |
| Tekla Capital Management LLC | 699,377 | $9,875,000 | 0.32% |